- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06388811
Validity and Reliability Study of the Turkish Version of the Early Osteoarthritis Questionnaire
Validity and Reliability Study of the Turkish Version of the Early Osteoarthritis
The symptoms of early osteoarthritis (OA) are quite similar to established knee OA, they differ, particularly in frequency, intensity, and severity. For this reason, in 2023, the International Symposium of intra-articular treatment (ISIAT) technical experts panel (TEP-technical experts panel) published for the first time a questionnaire designed to assess and monitor the follow-up and clinical progression of patients affected by early knee OA. Early management of knee OA is recommended by various guidelines because this approach may alter the course and clinical features of the disease, especially when considering disease-modifying agents that may delay disease progression.
Therefore, the assessment of early knee OA with a questionnaire may facilitate the follow-up of OA in the early stages of the disease when treatment is likely to be more effective. This approach will allow to reduce disability and improve patients' quality of life. While creating the Early Osteoarthritis Questionnaire (EOAQ), it was aimed to have a complete, short and easy-to-understand questionnaire and to ensure that the respondents could complete the questionnaire easily and in a short time. The EOAQ consists of 11 questions. The questions were divided into two different groups. While the first two questions were related with clinical characteristics, the other nine questions aimed to investigate the results reported by the patient. For each question, there are three responses depending on the number of episodes: Never, rarely (between one and three episodes) and frequently (more than three episodes) within a 6-month period. Turkish validity and reliability study of the EOAQ has not been conducted yet.
For the translation of the questionnaire, the guide recommended by Beaton et al. for the cultural adaptation of questionnaires will be used. According to this guideline the original EOAQ will be translated into Turkish by two experts independently of each other, and then a single Turkish version will be created by two experts working together. This Turkish version will then be translated back into English by an expert who can speak both languages at an advanced level. The experts will then evaluate the translation and adapt the questionnaire accordingly. After the completion of the translated form, 110 patients and 110 control group participants who applied to Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation and met the inclusion criteria will be included. The participants will be informed verbally and in writing about the purpose, duration and method of the study and will be asked to sign an "Informed Voluntary Consent Form" after their consent is obtained. Participants will fill in the Turkish version of the questionnaire. Along with the questionnaire, knee pain will be questioned with the Numeric Rating Scale (0=no pain, 10=the most severe pain you experience) and disability will be questioned with the WOMAC Questionnaire, whose Turkish validity and reliability study has been conducted. Test-retest method will be applied for reliability analyses; therefore, at least 30 patients among the patients included in the study will complete the questionnaire twice (the second evaluation will be 2 weeks after the first evaluation).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Fatma Merih Akpınar
- Phone Number: +905333558843
- Email: merihcaliskan@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
-
For the patient group :
Meeting the diagnostic criteria for early symptomatic knee OA
- In the absence of risk factors, two mandatory symptoms (pain when climbing up and down stairs and increased pain with overload) are present
- In the presence of 1 or 2 risk factors, at least pain when climbing up and down stairs is present among the two mandatory symptoms
- Presence of at least 1 mandatory symptom in the presence of 3 or more risk factors
- Over 40 years of age
- Signing the informed consent form
- Being able to read and write Turkish
- To be able to come to the follow-ups required by the study
For the control group:
- Absence of knee pain
- 18-40 years of age
- Signing the informed consent form
- Being able to read and write Turkish
- To be able to come to the follow-ups required by the study
Exclusion Criteria:
For the patient group:
- Active inflammatory arthritis
- The presence of widespread pain
- Being under 40 years of age
- Having stage 1-4 knee OA according to Kellgren and Lawrence
- Recent trauma or injury
- Symptom duration of more than 6 months
- Having a mental capacity, cognition level that prevents understanding and completing the questionnaire
For the control group:
- Having knee pain
- Under 18 years of age and over 40 years of age
- Having a mental capacity, cognition level that prevents understanding and completing the questionnaire
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Early Knee Osteoarthritis Patients
|
Self administered questionnaire
|
Population Without Knee Pain
|
Self administered questionnaire
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Numeric Rating Scale
Time Frame: Baseline, second week
|
Patients rate their level of pain between 0-10 during movement, rest and night, 0 indicates no pain, 10 indicates the worst imaginable pain
|
Baseline, second week
|
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: Baseline, second week
|
WOMAC consists of 24 items consisting of 3 subgroups that the patients answer themselves.
These subgroups include; pain intensity during various positions or movements, severity of joint stiffness and difficulty in performing daily functional activities.
It has 3 forms: 5-point Likert, 100 mm visual analogue scale and 11-box numerical evaluation scale.
The 5 point likert form will be filled in this study.
Higher scores indicate worse pain, stiffness, or physical function.
|
Baseline, second week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023/1162
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Early Knee Osteoarthritis
-
Istituto Ortopedico RizzoliCompletedKnee Chondropathy | Knee Early OsteoarthritisItaly
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom
-
National Yang Ming UniversityFar Eastern Memorial HospitalCompletedMedial Knee OsteoarthritisTaiwan
Clinical Trials on Early Osteoarthritis Questionnaire
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
Centre Oscar LambretNational Cancer Institute, France; Ligue contre le cancer, France; Région Nord-Pas...CompletedGastric Cancer | Esophageal Cancer | Bile Duct Cancer | Pancreas Cancer | Gastroesophageal CancerFrance
-
Smith & Nephew, Inc.Completed
-
Baylor College of MedicineM.D. Anderson Cancer Center; Agency for Healthcare Research and Quality (AHRQ)Completed
-
Brigham and Women's HospitalCompletedKnee Osteoarthritis
-
US Department of Veterans AffairsCompletedOsteoarthritisUnited States
-
Marmara UniversityCompletedKnee Osteoarthritis | Hip OsteoarthritisTurkey
-
Lund UniversitySuspended
-
Sport Injury Prevention Research CentreUnknownOsteoarthritis Knees Both Post-TraumaticCanada
-
Lund UniversityCompletedOsteoarthritis | Patient Education as TopicSweden